Defense World
19 Jan 2026, 07:20 UTC · 34w ago
Verdict
Headline takes no side. We score VTYX −0.60 across two claims — strongly bearish.
−0.60strongly bearish
More negative than 82% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Short interest in Ventyx Biosciences grew by 19.8% between December 15th and December 31st.
More negative than 80% of claims this week
Approximately 12.5% of Ventyx Biosciences' shares are currently sold short.
So whatWhile significant, this level of short interest is a moderate signal of skepticism but also creates a potential catalyst for a short squeeze if positive news emerges.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 66% of claims this week
Which stocks this story touches
More negative than 82% of ticker scores this week
The company experienced a significant increase in short interest, indicating growing bearish sentiment among investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
+0.8%
Price is moving against the score
$14.00 vs $13.89 close before publication (Jan 16) · not market-adjusted
VTYX chart →
